Always Look on the Bright Side of (Cell) Death: Cytotoxicity Assays for Antibody Drug Conjugate Development
In this webinar, you will learn:
- The benefits of drug screening in 3D cultures and how using optimized 3D cell-based assays address the challenges of measuring cell health in 3D cultures, leading to more effective assessment of key outcomes, such as viability and apoptosis
- The role of bioassays in ADC developability and lead selection
- How complex co-culture and 3D in vitro models enable researchers to select the best candidate to take forward for clinical development
Summary
Speakers

Darren Heywood, PhD
Product Manager, Cell Health
Promega UK

Grant Harradence
Manager
Abzena

Robert Francis, PhD
Manager and Microscopy Lead
Abzena